Cancer Protein CA125 Blocks Investigational Therapy Farletuzumab’s Anti-Tumor Effectiveness

July 21, 2017 4:03 pm

The protein CA125, which is commonly expressed on the surface of ovarian cancer cells and is secreted into the bloodstream, was found to block the activity of investigational drug farletuzumab. Farletuzumab is currently in clinical development for the treatment of … Read more